Clinical Trials

Conditions:   Alzheimer's Disease;   Amyotrophic Lateral Sclerosis;   Brain Injury;   Huntington's Disease;   Multiple Sclerosis;   Parkinson's Disease;   Stroke;   Spinal Cord Injury
Intervention:   Other: Laughter Therapy
Sponsor:   Brown, Theodore R., M.D., MPH
Recruiting - verified July 2016

Condition:   ALS
Interventions:   Other: phenotyping Tcells;   Other: Supplementation in vitamin D
Sponsors:   University Hospital, Montpellier;   ARSLA
Not yet recruiting - verified April 2016

Conditions:   Hemorrhagic Shock;   Peritonitis
Intervention:   Other: Advanced Life Support
Sponsor:   Temple University
Not yet recruiting - verified June 2016

Condition:   Amyotrophic Lateral Sclerosis (ALS)
Intervention:   Procedure: Lumbar puncture
Sponsor:   Iron Horse Diagnostics, Inc.
Recruiting - verified April 2016

Conditions:   Leukemia;   Lymphoma;   Myeloma;   Myeloproliferative Diseases
Interventions:   Drug: Busulfan;   Drug: Fludarabine;   Drug: Clofarabine;   Drug: Rabbit ATG;   Radiation: Total Body Irradiation (TBI);   Procedure: Cord Blood Infusions;   Drug: Rituximab;   Drug: Cyclophosphamide;   Procedure: Natural Killer Cell Infusion;   Drug: Melphalan;   Drug: Mesna
Sponsor:   M.D. Anderson Cancer Center
Recruiting - verified December 2016

Conditions:   Acute Leukemia;   Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia/Lymphoma;   Burkitt's Lymphoma;   Natural Killer Cell Malignancies;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndrome;   Large-cell Lymphoma;   Hodgkin Lymphoma;   Multiple Myeloma;   Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Marginal Zone B-cell Lymphoma;   Follicular Lymphoma;   Lymphoplasmacytic Lymphoma;   Mantle-cell Lymphoma;   Prolymphocytic Leukemia;   Bone Marrow Failure Syndromes;   Myeloproliferative Syndromes

Condition:   KIDNEY TRANSPLANTATION
Interventions:   Drug: Basiliximab;   Drug: Thymoglobulin
Sponsor:   University of Pennsylvania
Suspended - verified March 2016

Condition:   Motor Neuron Disease, Upper
Intervention:   Drug: dalfampridine
Sponsors:   Weill Medical College of Cornell University;   Hospital for Special Surgery, New York
Recruiting - verified November 2016

Condition:   Churg-Strauss Syndrome
Intervention:   Biological: HPC cell infusion
Sponsor:   Seah H Lim, MD, PhD
Not yet recruiting - verified March 2016

Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Drug: ibudilast
Sponsors:   MediciNova;   Massachusetts General Hospital;   South Shore Neurologic Associates
Recruiting - verified February 2017